That is essential, because the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (legacy report prediction). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. This was an advancement nearly nobody observed. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of investment chances in this area, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (biotech stocks). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back possibly considerably before going higher - diplomatic relations. I've been covering bitcoin for a long period of time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. But that's not the huge question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. brownstone research. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous fantastic personal companies on the edge of striking the general public markets And I have actually been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your area for totally free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (legacy report prediction). And when it pertains to tech investing, we leave it to the experts. The good news is, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing specialists we understand (jeff brown 1 biotech). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential growth and developing amazing chances for financiers. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown 2020 predictions. However in spite of what lots of readers may think, this is a pattern that's simply getting started. Even though the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown investment prediction). Losing 2 months of production and sales actually impacts the number of 5G devices are offered in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More importantly, the delays brought on by the pandemic produced a lots of suppressed demand. Which demand is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - democratic republic. Which's not my only 5G forecast When I've spoken about 5G in the past, I have actually described its 3 different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Phase 3, 5G services begin to be provided (jeff brown biotech pick). That's when we begin to see applications working on 5G networks. Believe of things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: Many people do not truly appreciate the innovation. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances moving forward will be massive. Stepping far from 5G, the next crucial technology I foresee in 2021 is CRISPR hereditary editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For several years, CRISPR was primarily a niche technology that wasn't well understood. And throughout that time, there were actually just 3 business running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire industry is successfully a greenfield chance.
There's room for many business to exist in this space. jeff brown prediction. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential since the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental procedure. But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced using this innovation. This was one of those advancements that nearly no one observed. However it's going to have profound ramifications for treating illness. And, obviously, there will be plenty of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown biotech stocks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. united arab emirates. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we could not separately verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the market. He's always on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted some of the biggest financial events of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it ideal every time, but Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent financial research study publisher. Brownstone Research offers numerous research services with a wide array of specializations - jeff brown biotech stock pick for 2020.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - social media. On its website, Brownstone says its mission is to supply retail investors with professional-grade research: "For too long, the finest financial investment research study has actually not been readily available to private investors. It has been usually scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown predictions 2021. The objective of Brownstone Research study is to make that kind of exclusive research study offered to any financiers aiming to gain an edge in the marketplaces. The objective is simple to provide distinct and successful investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you know even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. biotech stock. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown believes S.A.V. jeff brown top stock pick 2021. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: synthetic intelligence and electrical automobiles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing except the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving cars and truck stocks have been big this year, however the Wall Street machine has approved hype without much concrete outcome. Despite an extreme boost in competitors over the past couple of years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Essentially, this technology would allow you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the automobile and press a button on an app that informs the vehicle to "join the fleet." Next thing you understand, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial chunk of the profits. It sounds outrageous, but it might be closed than you think.